{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:02:49Z","timestamp":1782975769531,"version":"3.54.5"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent high-risk human papillomavirus (HR-HPV) infection drives cervical carcinogenesis, often exacerbated by vaginal dysbiosis and localized immune dysfunction. Kushen Gel shows clinical promise, yet its impact on microbial-immune crosstalk during HR-HPV clearance remains unclear. This study elucidates the microbial remodeling and immune shifts associated with Kushen Gel-mediated HR-HPV regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis of 230 vaginal swabs (130 pre-treatment, 100 post-treatment) via 16S rRNA sequencing characterized community structural shifts. Subsequently, a prospective cohort of 35 patients with persistent HR-HPV infection (defined as laboratory-confirmed positive HR-HPV DNA for \u226512\u202fmonths) validated clinical outcomes (HR-HPV clearance, vaginal pH, Nugent scores) alongside paired 16S rRNA sequencing and ELISA-based quantification of cervicovaginal cytokines (IL-8, IL-6, TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      , IFN-\n                      <jats:italic>\u03b3<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Kushen Gel intervention significantly decreased microbial alpha diversity and was associated with a distinct beta-diversity shift toward a stable,\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      -dominant state. Models (LEfSe, Random Forest) identified a marked reduction in pathobionts (\n                      <jats:italic>Gardnerella<\/jats:italic>\n                      ,\n                      <jats:italic>Sneathia<\/jats:italic>\n                      ,\n                      <jats:italic>Prevotella<\/jats:italic>\n                      ) post-treatment. In the prospective cohort, the HR-HPV clearance rate reached 82.9% (29\/35) after three menstrual cycles, synchronized with significant reductions in mean vaginal pH (4.85\u202f\u00b1\u202f0.42 to 4.12\u202f\u00b1\u202f0.35,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.001) and an 85.7% Nugent score normalization rate. Crucially, Kushen Gel treatment was associated with a profound shift from a pro-inflammatory to an anti-viral immune microenvironment. Pro-inflammatory markers (IL-8, IL-6, TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      ) plummeted significantly (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.0001), while anti-viral IFN-\n                      <jats:italic>\u03b3<\/jats:italic>\n                      exhibited a robust increase (3.2\u202f\u00b1\u202f1.1 to 18.6\u202f\u00b1\u202f5.4\u202fpg.\/mL,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.0001), particularly in responders.\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      abundance positively correlated with IFN-\n                      <jats:italic>\u03b3<\/jats:italic>\n                      (\n                      <jats:italic>r<\/jats:italic>\n                      =\u202f0.68) and inversely with IL-8 (\n                      <jats:italic>r<\/jats:italic>\n                      =\u202f\u22120.54).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Kushen Gel is associated with HR-HPV clearance and concurrent vaginal microenvironment remodeling, marked by suppressed anaerobic-driven inflammation and an enhanced IFN-\n                      <jats:italic>\u03b3<\/jats:italic>\n                      -associated anti-viral niche dominated by\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      . These findings biologically support using Kushen Gel to manage vaginal dysbiosis and HR-HPV regression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1841519","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:33:16Z","timestamp":1782970396000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of key vaginal microbial signatures and immune remodeling associated with HR-HPV clearance following Kushen Gel treatment: a longitudinal analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuheng","family":"Pan","sequence":"additional","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ma","sequence":"additional","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihan","family":"Wu","sequence":"additional","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[{"name":"Hohhot Maternal and Child Health Care Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"10732748251336415","DOI":"10.1177\/10732748251336415","article-title":"Advances and challenges in cervical Cancer: from molecular mechanisms and global epidemiology to innovative therapies and prevention strategies","volume":"32","author":"Hakim","year":"2025","journal-title":"Cancer Control"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1645748","DOI":"10.3389\/fonc.2025.1645748","article-title":"Epidemiological characteristics and risk factors of high-risk HPV infection, cervical cancer, and precancerous lesions among women in southwestern China","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1618846","DOI":"10.3389\/fcimb.2025.1618846","article-title":"Association between vaginal microecological alterations and high-risk human papillomavirus infection: a cross-sectional study","volume":"15","author":"Peng","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"112476","DOI":"10.1016\/j.isci.2025.112476","article-title":"Exploring the role of the vaginal microbiome in HPV infection dynamics: a prospective cohort study","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4274\/jtgga.galenos.2019.2019.0051","article-title":"Vaginal microbiota and human papillomavirus: a systematic review","volume":"21","author":"Mortaki","year":"2020","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1733315","DOI":"10.3389\/fmicb.2025.1733315","article-title":"Microbial influences on HPV infection and cervical carcinogenesis: emerging evidence from the vaginal microbiome","volume":"16","author":"Feng","year":"2025","journal-title":"Front Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"792787","DOI":"10.3389\/fcimb.2021.792787","article-title":"Contribution of Lactobacillus iners to vaginal health and diseases: a systematic review","volume":"11","author":"Zheng","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41522-025-00839-y","article-title":"Microbial regulators of physiological and reproductive health in women of reproductive age: their local, proximal and distal regulatory roles","volume":"11","author":"Cheng","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/amh70020019","article-title":"Microbial pathogens linked to vaginal microbiome dysbiosis and therapeutic tools for their treatment","volume":"70","author":"Borrego-Ruiz","year":"2025","journal-title":"Acta Microbiol Hell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/microorganisms8101587","article-title":"Gut microbiota and immune system interactions","volume":"8","author":"Yoo","year":"2020","journal-title":"Microorganisms"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2147\/CMAR.S527913","article-title":"Modulation of chronic cytokine dysregulation in cervical Cancer: potential biomarkers and therapeutic targets","volume":"17","author":"Obeagu","year":"2025","journal-title":"Cancer Manag Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e17354","DOI":"10.5812\/jjm.8(4)2015.17354","article-title":"Th1 cytokine production induced by Lactobacillus acidophilus in BALB\/c mice bearing transplanted breast tumor","volume":"8","author":"Imani Fooladi","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/ph15111384","article-title":"Determination of antioxidant, cytotoxicity, and acetylcholinesterase inhibitory activities of alkaloids isolated from Sophora flavescens ait. Grown in dak Nong, Vietnam","volume":"15","author":"Thang","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1353234","DOI":"10.3389\/fphar.2024.1353234","article-title":"A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine","volume":"15","author":"Wei","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"105778","DOI":"10.1016\/j.phrs.2021.105778","article-title":"Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer","volume":"171","author":"Chen","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1707853","DOI":"10.3389\/fmed.2025.1707853","article-title":"Kushen gel for the treatment of high-risk human papillomavirus infection: a systematic review and meta-analysis","volume":"12","author":"Li","year":"2025","journal-title":"Front Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.7150\/jca.22427","article-title":"Anti-cervical Cancer role of Matrine, oxymatrine and Sophora Flavescens alkaloid gels and its mechanism","volume":"9","author":"Zhou","year":"2018","journal-title":"J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3892\/ol.2022.13230","article-title":"Matrine exerts antitumor activity in cervical cancer by protective autophagy via the Akt\/mTOR pathway in vitro and in vivo","volume":"23","author":"Zhang","year":"2022","journal-title":"Oncol Lett"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/10732748251336415","article-title":"Immune cellular response to HPV: current concepts","volume":"8","author":"Gon\u00e7alves","year":"2004","journal-title":"Braz J Infect Dis Off Publ Braz Soc Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1142\/S0192415X14500888","article-title":"In vitro immunomodulatory activity of oxymatrine on toll-like receptor 9 signal pathway in chronic hepatitis B","volume":"42","author":"Yao","year":"2014","journal-title":"Am J Chin Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.7150\/jca.86043","article-title":"Comparative efficacy and safety of Chinese patent medicines for cervical high-risk human papillomavirus infection: a Bayesian network Meta-analysis","volume":"14","author":"Bin","year":"2023","journal-title":"J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12985-023-02037-8","article-title":"The interplay between human papillomavirus and vaginal microbiota in cervical cancer development","volume":"20","author":"Sharifian","year":"2023","journal-title":"Virol J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/microorganisms11030636","article-title":"Lactobacilli and their probiotic effects in the vagina of reproductive age women","volume":"11","author":"Pendharkar","year":"2023","journal-title":"Microorganisms."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3389\/fmicb.2016.01936","article-title":"Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique?","volume":"7","author":"Miller","year":"2016","journal-title":"Front Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.3390\/cancers14194909","article-title":"Does Lactobacillus exert a protective effect on the development of cervical and endometrial Cancer in women?","volume":"14","author":"Fr\u0105szczak","year":"2022","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/biology14081081","article-title":"Harnessing the power of microbiota: how do key Lactobacillus species aid in clearing high-risk human papilloma virus infection and promoting the regression of cervical dysplasia?","volume":"14","author":"K\u0119czkowska","year":"2025","journal-title":"Biology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/healthcare13060599","article-title":"The interplay between cervicovaginal microbiota diversity, Lactobacillus profiles and human papillomavirus in cervical cancer: a systematic review","volume":"13","author":"Incognito","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2025.03.13.643085","DOI":"10.1101\/2025.03.13.643085","article-title":"Temporal dynamics of the vaginal microbiome and host immune markers before, during, and after metronidazole treatment for bacterial vaginosis","author":"Williams","year":"2025","journal-title":"bioRxiv"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/medicina61050847","article-title":"The vaginal microbiota, human papillomavirus, and cervical dysplasia\u2014a review","volume":"61","author":"Kazlauskait\u0117","year":"2025","journal-title":"Medicina (Mex)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13027-024-00573-8","article-title":"Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer","volume":"19","author":"Shen","year":"2024","journal-title":"Infect Agent Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1367233","DOI":"10.3389\/fcimb.2024.1367233","article-title":"The role of sialidases in the pathogenesis of bacterial vaginosis and their use as a promising pharmacological target in bacterial vaginosis","volume":"14","author":"Chen","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e0015225","DOI":"10.1128\/msphere.00152-25","article-title":"Human papillomavirus 16 mitigates Sneathia vaginalis-induced damage to cervical keratinocytes","volume":"10","author":"Bridy","year":"2025","journal-title":"mSphere"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/1040841X.2021.1905606","article-title":"Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes","volume":"47","author":"Theis","year":"2021","journal-title":"Crit Rev Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.virs.2025.11.004","article-title":"Topoisomerase II\u03b1 orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication","volume":"40","author":"Liu","year":"2025","journal-title":"Virol Sin"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41368-019-0069-7","article-title":"Proinflammatory cytokine TNF\u03b1 promotes HPV-associated oral carcinogenesis by increasing cancer stemness","volume":"12","author":"Hong","year":"2020","journal-title":"Int J Oral Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/373219","article-title":"Antitumor activities of Kushen: literature review","volume":"2012","author":"Sun","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12879-024-09074-w","article-title":"Vaginal pH value can affect the susceptibility to human papillomavirus infection","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.2147\/IJGM.S545252","article-title":"Vaginal microecology disturbance and immune dysregulation are associated with human papillomavirus infection: insights from a two-year study of vaginal microecology","volume":"18","author":"Sheng","year":"2025","journal-title":"Int J Gen Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e02677-25","DOI":"10.1128\/mbio.02677-25","article-title":"The vaginal microbiome, papillomavirus infection, and cervical cancer: established associations in search of model systems and mechanistic answers","volume":"17","author":"Passarelli","year":"2026","journal-title":"MBio"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/antibiotics10030318","article-title":"Research Progress on antibacterial activities and mechanisms of natural alkaloids: a review","volume":"10","author":"Yan","year":"2021","journal-title":"Antibiotics"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"119107","DOI":"10.1016\/j.jep.2024.119107","article-title":"Kushen gel combined with antifungal drugs for the treatment of vulvovaginal candidiasis: a systematic review and meta-analysis of randomized controlled trials","volume":"338","author":"Yu","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1124591","DOI":"10.3389\/fcimb.2023.1124591","article-title":"Interactions between microbiota and cervical epithelial, immune, and mucus barrier","volume":"13","author":"Dong","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41467-022-28724-8","article-title":"HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by lactobacilli as amino acid sources","volume":"13","author":"Lebeau","year":"2022","journal-title":"Nat Commun"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1841519\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:33:16Z","timestamp":1782970396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1841519\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":43,"alternative-id":["10.3389\/fmed.2026.1841519"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1841519","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1841519"}}